| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $361.1M | -1.4% |
| Cost of Revenue | $171.4M | -3.3% |
| Gross Profit | $189.7M | +0.4% |
| R&D Expense | $102.6M | +3.8% |
| SG&A Expense | $49.2M | -5.0% |
| Operating Income | -$737K | +89.6% |
| Interest Expense | $4.4M | -10.4% |
| Pre-tax Income | -$10.9M | -126.6% |
| Income Tax | -$69K |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $48.2M | +4.7% |
| Short-term Investments | $127.1M | +7.1% |
| Accounts Receivable | $70.8M | +24.6% |
| Inventory | $85.0M | -14.5% |
| Current Assets | $339.2M | +3.9% |
| Total Assets | $545.2M | +11.5% |
| Current Liabilities | $126.5M | -61.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $58.7M | -54.2% |
| Capital Expenditures | $12.9M | -24.8% |
| Investing Cash Flow | -$48.0M | +75.1% |
| Financing Cash Flow | -$8.9M | -156.9% |
| Free Cash Flow | $45.9M | -58.7% |
| -143.9% |
| Net Income | -$10.8M | -126.6% |
| EPS (Basic) | -$0.37 | -125.3% |
| EPS (Diluted) | -$0.37 | -126.6% |
| Long-term Debt |
| $280.9M |
| -0.9% |
| Total Liabilities | $336.0M | -1.0% |
| Stockholders' Equity | $209.2M | +39.6% |